tiprankstipranks
Trending News
More News >
Aehr Test Systems (AEHR)
NASDAQ:AEHR

Aehr Test Systems (AEHR) AI Stock Analysis

Compare
1,261 Followers

Top Page

AE

Aehr Test Systems

(NASDAQ:AEHR)

69Neutral
Aehr Test Systems shows strong historical financial performance and growth potential, particularly in the AI and semiconductor markets. However, recent financial challenges, potential tariff impacts, and technical analysis indicate significant risks. The company's valuation suggests fair pricing, but the lack of a dividend and current stock price trends call for caution. Overall, the stock warrants a moderate score due to its growth prospects tempered by current financial and market challenges.

Aehr Test Systems (AEHR) vs. S&P 500 (SPY)

Aehr Test Systems Business Overview & Revenue Model

Company DescriptionAehr Test Systems (AEHR) is a leading provider of semiconductor test and reliability qualification equipment. The company operates within the technology and manufacturing sectors, focusing primarily on the development, production, and sale of systems designed to reduce the cost of testing and burn-in for semiconductor devices. Aehr Test Systems offers a range of products such as wafer-level test and burn-in systems, known for their efficiency and high throughput capabilities, which are essential for ensuring the reliability and performance of semiconductors used in various electronic applications.
How the Company Makes MoneyAehr Test Systems generates revenue through the sale of its semiconductor test and burn-in equipment to a broad range of customers, including semiconductor manufacturers and other electronics companies. The company's key revenue streams include the direct sale of its proprietary test systems, as well as associated accessories and spare parts. Additionally, Aehr Test Systems may earn income from service and maintenance contracts related to its equipment. Significant partnerships with major semiconductor companies and continuous innovation in test technologies also contribute to its earnings by enhancing product offerings and expanding market reach.

Aehr Test Systems Financial Statement Overview

Summary
Aehr Test Systems has demonstrated strong revenue growth and improved profitability over recent years. However, the TTM results indicate potential challenges with a decline in revenue, profitability, and cash flow. The company's low leverage is a positive factor, but maintaining cash flow and reversing recent negative trends will be crucial for sustaining growth.
Income Statement
82
Very Positive
Aehr Test Systems has shown a strong recovery with consistent revenue growth from 2020 to 2024. The company reported a significant improvement in net income, turning negative net income in 2020 into a substantial profit in 2024. However, the TTM data indicates a decline in revenue and a negative EBIT, which could be concerning if the trend continues.
Balance Sheet
78
Positive
The balance sheet shows a healthy equity position with a growing stockholders' equity from 2020 to 2024. The debt-to-equity ratio is low, indicating low financial leverage. However, the increase in total liabilities and a decline in cash reserves in the TTM period are areas to watch.
Cash Flow
70
Positive
Cash flow from operations has fluctuated significantly, with negative cash flow in the TTM period. Free cash flow has been inconsistent, which may affect the company's ability to finance new projects without external funding. The company's ability to convert net income into cash is a concern given the negative operating cash flow in the latest period.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
50.73M66.22M64.96M50.83M16.60M22.29M
Gross Profit
24.08M32.54M32.75M23.66M6.03M8.37M
EBIT
-859.00K10.08M13.38M5.79M-4.18M-2.54M
EBITDA
450.00K11.44M13.82M7.80M-3.85M-2.16M
Net Income Common Stockholders
22.02M33.16M14.56M9.45M-2.03M-2.80M
Balance SheetCash, Cash Equivalents and Short-Term Investments
8.67M49.16M47.91M31.48M4.58M5.43M
Total Assets
16.97M127.91M98.14M62.33M21.66M20.57M
Total Debt
302.00K6.20M6.30M1.01M4.82M3.94M
Net Debt
-8.37M-42.96M-23.75M-30.48M241.00K-1.49M
Total Liabilities
5.18M16.32M22.54M11.34M10.22M6.52M
Stockholders Equity
11.79M111.59M75.60M50.99M11.45M14.08M
Cash FlowFree Cash Flow
-5.92M1.01M8.65M1.09M-2.93M-2.19M
Operating Cash Flow
-5.09M1.76M10.01M1.51M-2.70M-2.02M
Investing Cash Flow
-11.44M17.25M-18.66M-416.00K-227.00K-163.00K
Financing Cash Flow
1.07M139.00K7.32M25.76M1.96M2.17M

Aehr Test Systems Technical Analysis

Technical Analysis Sentiment
Negative
Last Price8.13
Price Trends
50DMA
9.46
Negative
100DMA
11.37
Negative
200DMA
12.73
Negative
Market Momentum
MACD
-0.62
Positive
RSI
36.69
Neutral
STOCH
15.30
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AEHR, the sentiment is Negative. The current price of 8.13 is below the 20-day moving average (MA) of 8.34, below the 50-day MA of 9.46, and below the 200-day MA of 12.73, indicating a bearish trend. The MACD of -0.62 indicates Positive momentum. The RSI at 36.69 is Neutral, neither overbought nor oversold. The STOCH value of 15.30 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AEHR.

Aehr Test Systems Risk Analysis

Aehr Test Systems disclosed 21 risk factors in its most recent earnings report. Aehr Test Systems reported the most risks in the “Tech & Innovation” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Aehr Test Systems Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TETER
75
Outperform
$12.78B23.9220.29%0.60%5.52%16.59%
69
Neutral
$260.28M11.2921.69%-14.48%46.79%
60
Neutral
$2.29B33.547.50%15.16%-15.16%
57
Neutral
$20.24B9.51-13.28%2.72%5.43%-24.54%
55
Neutral
$984.79M42.132.77%20.92%
50
Neutral
$1.71B271.280.31%2.52%-4.92%-85.39%
48
Neutral
$707.87M-7.73%-36.86%-351.11%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AEHR
Aehr Test Systems
8.13
-3.70
-31.28%
COHU
Cohu
14.30
-17.71
-55.33%
FORM
Formfactor
26.23
-19.64
-42.82%
KLIC
Kulicke & Soffa
29.40
-18.40
-38.49%
TER
Teradyne
72.29
-36.73
-33.69%
UCTT
Ultra Clean Holdings
19.69
-25.76
-56.68%

Aehr Test Systems Earnings Call Summary

Earnings Call Date: Apr 8, 2025 | % Change Since: 19.91% | Next Earnings Date: Jul 17, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted strong revenue growth and successful market diversification into AI and other segments, but was overshadowed by uncertainty from recent tariff announcements and challenges in maintaining margins. Despite these challenges, the company remains optimistic about long-term growth opportunities.
Highlights
Record Revenue Growth
Third quarter revenue reached $18.3 million, a 142% increase compared to $7.6 million in Q3 last year, driven by high-power FOX-XP system shipments for AI processors.
Diversification Success
AI processors now represent over 35% of Aehr's business this year, a significant diversification from the previous reliance on silicon carbide.
Strategic Market Expansions
Aehr entered several new markets including GaN power semiconductors, AI processors, silicon photonics, and hard disk drives.
Successful Product Integration
The integration of InCal Technology's products boosted Aehr's manufacturing capabilities and expanded offerings in AI markets.
Lowlights
Tariff-Related Uncertainty
The recent U.S. tariff announcements have created uncertainty regarding potential delays or pauses in customer orders and deliveries.
Temporary Guidance Withdrawal
Due to tariff impacts and potential customer order delays, Aehr has temporarily withdrawn its fiscal 2025 guidance.
Gross Margin Challenges
Non-GAAP gross margin for Q3 was flat at 42.7% due to one-time charges and high manufacturing overhead.
Increased Operating Expenses
Non-GAAP operating expenses rose by 34% year-over-year, driven by InCal integration costs and increased legal fees.
Company Guidance
During the Aehr Test Systems Fiscal 2025 Third Quarter Financial Results Call, the company reported a third-quarter revenue of $18.3 million, marking a significant 142% increase compared to the same period last year. This growth was primarily driven by shipments of the new high-power FOX-XP solution for AI processors. The company also noted a backlog of $22 million and highlighted its strategic expansion into AI processors, gallium nitride, and flash memory markets. Despite withdrawing guidance for fiscal 2025 due to uncertainties related to recent tariff announcements, Aehr Test Systems emphasized its robust supply chain and diversified market opportunities, projecting a total addressable market of $1 billion by 2027, with wafer and package part burn-in systems accounting for $500 million each.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.